[1] Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211-228.[2] Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12): 4279-4295.[3] Konno M, Hamabe A, Hasegawa S, et al. Adipose-derived mesenchymal stem cells and regenerative medicine. Dev Growth Differ. 2013;55(3):309-318.[4] Safford KM, Hicok KC, Safford SD, et al. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun. 2002;294(2):371-379.[5] D'Andrea F, De Francesco F, Ferraro GA, et al. Large-scale production of human adipose tissue from stem cells: a new tool for regenerative medicine and tissue banking. Tissue Eng Part C Methods. 2008;14(3):233-242.[6] Cao Y, Sun Z, Liao L, et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun. 2005;332(2):370-379.[7] Konno M, Hamazaki TS, Fukuda S, et al. Efficiently differentiating vascular endothelial cells from adipose tissue-derived mesenchymal stem cells in serum-free culture. Biochem Biophys Res Commun. 2010;400(4):461-465.[8] Pfeffer MA, Braunwald E. Experimental observations and clinical implications. Circulation.1990;81(4):1161-1172.[9] Rodriguez AM, Pisani D, Dechesne CA, et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immu-nocompetent mdx mouse. J Exp Med. 2005;201(9):1397-1405.[10] Herold K C, Gitelman SE, Masharani U, et al. A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes. 2005;54(6):1763-1769.[11] Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med. 2005;352(25):2598-2608.[12] Santana A, Ensenat-Waser R, Arribas MI, et al. Insulin-producing cells derived from stem cells: recent progress and future directions. J Cell Mol Med. 2006;10(4): 866-883.[13] Gitelman SE, Haller MJ, Schatz D. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 2009; 302(6): 624; author reply 624-625. [14] Goh BC, Thirumala S, Kilroy G, et al. Cryopreservation characteristics of adipose-derived stem cells: mintenance of Differentiation potential and viability. J Tissue Eng Regen Med. 2007;1(4):322-324.[15] Gruber CJ, Tschugguel W, Schneeberger C, et al. Production and actions of estrogens. N Engl J Med. 2002;346(5): 340-352.[16] Nickstick EA, Martello DD, Ray SK, et al .Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis. J Neurosci Res. 2006;84(5):1064-1075.[17] 田莉,蒋知新.雌激素对血管作用的研究进展[J].中国民康医志, 2005,17(11):685-687.[18] 周筠,张桦,蔡德鸿.雌激素对卵巢切除大鼠肾脏VDR mRNA 表达的影响[J].上海交通大学学报,2008,28(11):1474-1475.[19] ErhardtLR, HobbsFD. A global survey of physicians perceptions on cholesterol management: the from the heart study. Int J Clin Pract. 2007;61(7):1078-1085.[20] Yu CP, Ho JY, Huang YT, et al. Estrogen Inhibits renal cell carcinoma cell progression through estrogen receptor-β activation. PLoS One. 2013;8(2):e56667.[21] Rajalin AM, Pollock H, Aarnisalo P. ERR a regulates osteoblastic and adipogenic differentiation of mouse bone marrow mesenchymal stem cells. Biochem Biophys Res Commun. 2010;396(2):477-482.[22] Lee RH, Kim B, Choi I, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem. 2004; 14(4-6):311-324.[23] 吴畏,郑红光,张德伟,等.肾脂肪囊来源脂肪干细胞的体外培养及其生物学特性的研究[J]. 细胞与分子免疫学杂志,2010,26(11): 1078-1081.[24] Igor N, Oleg S. Long-term results of fat transplantation: clinical and histologic studies. Plast Reconstr Surg. 1994; 94(3):496-506.[25] Heino TJ, Hentunen TA. Differentiation of osteoblasts and osteocytes from mesenchymal stem cells. Curr Stem Cell Res Ther. 2008;3(2):131-145.[26] B ckesj CM, Li Y, Lindgren U, et al. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. Cells Tissues Organs. 2009;189(1-4):93-97.[27] Okazaki R, Inoue D, Shibata M, et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology. 2002;143(6):2349-2356.[28] Banfi A, Muraglia A, Dozin B, et al. Proliferation kinetices and differentiation potential of exvivo expanded human bone marrow stromal cell:Implication for their use in cell therapy. Exp Hematol. 2000;28(6):707-715.[29] Beresford JN, Bennett JH, Devlin C, et al. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci. 1992;102 ( Pt 2):341-351.[30] Ahdjoudj S, Lasmoles F, Oyajobi BO, et al. Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells. J Cell Biochem. 2001;81(1):23-38. [31] Dieudonne MN, Leneveu MC, Giudicelli Y, et al. Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol. 2004;286(3):655-661.[32] Hong L, Colpan A, Peptan IA, et al. 17-Beta estradiol enhances osteogenic and adipogenic differentiation of human adipose-derived stromal cells. Tissue Eng. 2007; 13(6):1197-1203.[33] 訾利影,郑红光,张德伟,等.氯甲基苯甲酰胺标记大鼠肾脂肪囊来源脂肪间充质干细胞的可行性[J].中国组织工程研究,2012, 16(19): 3520-3524.[34] Ramírez-Zacarías JL, Castro-Muñozledo F, Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red. Histochemistry. 1992;97(6):493-497. |